BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Adipose tissue
,
Pharmacogenetics
,
Acetaminophen
,
rs4950928
,
FXYD4
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Epidermal growth factor receptor kinase substrate 8
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon mucosa
Pericardium
Cervix
Adipose tissue subcutaneous
Myometrium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bacterial infection due to Bacillus
Ascites
Listeriosis
Infection due to Pseudomonas
Salmonella infection
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
U 93631
Sulfadiazine
5'-Guanylic Acid
Cyclopenthiazide
Phosphatidylserines
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir378a
CLN6
SLC37A4
EMX2
Ar
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
OMIM - Congenital deafness
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
PBMC of patients with major depression (MD) or subsyndromal symptomatic depression (SSD)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Epidermal growth factor receptor kinase substrate 8
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblast…
Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor R…
Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small C…
Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast…
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cel…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ